Search Within

Charles Rudin

  1. "MSK Grad Students"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (17)
  3. Editorial (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (45)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (45)
  3. Department of Medicine (45)
  4. GSK Faculty (45)
  5. MSK Grad Students (45)
  6. Solid Tumor Oncology Division (45)

More Groups

People
  1. Elisa De Stanchina (17)
  2. Triparna Sen (13)
  3. Alvaro Quintanal Villalonga (11)
  4. Jason Lewis (10)
  5. David Solit (9)
  6. Michael Berger (9)

More People

Years
  1. 2024 (3)
  2. 2023 (5)
  3. 2022 (11)
  4. 2021 (8)
  5. 2020 (10)
  6. 2019 (3)

More Years

Publications
  1. Cancer Research (8)
  2. Cancer Cell (4)
  3. Clinical Cancer Research (3)
  4. Journal of Nuclear Medicine (3)
  5. Journal of Thoracic Oncology (3)
  6. Cell (2)

More Publications

Publishers
  1. American Association for Cancer Research (13)
  2. Cell Press (12)
  3. Nature Publishing Group (7)
  4. Elsevier Inc. (3)
  5. Society of Nuclear Medicine (3)
  6. American Society of Clinical Oncology (2)

More Publishers

Results (45)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Targeting TROP-2 in diffuse pleural mesothelioma
    Meeting Abstract

    Offin, M. D.; Tischfield, S.; Manoj, P.; Agrawal, P.; Tendler, S.; Pratt, E. C.; Travis, W.; Rimner, A.; Simone, C. B.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Automated real-world data integration improves cancer outcome prediction
    Journal Article

    Jee, J.; Fong, C.; Pichotta, K.; Tran, T. N.; Luthra, A.; Waters, M.; Fu, C.; Altoe, M.; Liu, S. Y.; Maron, S. B.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Radiotheranostics targeting Delta-like ligand 3 expressing small-cell lung cancers
    Meeting Abstract

    Tendler, S.; Hoang, T.; Bauer, D.; Korsen, J.; Carter, L.; Michel, A.; Degregorio, R.; Pillarsetty, N.; Poirier, J. T.; Lewis, J. S.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance
    Journal Article

    Zavitsanou, A. M.; Pillai, R.; Hao, Y.; Wu, W. L.; Bartnicki, E.; Karakousi, T.; Rajalingam, S.; Herrera, A.; Karatza, A.; Rashidfarrokhi, A.; more...
    Cell Reports (2023)

    Fulltext@MSK | Save
  • A theranostic approach: Imaging and therapy of delta-like ligand 3–expressing small cell lung cancers
    Meeting Abstract

    Tendler, S.; Hoang, T. T.; Bauer, D.; Korsen, J.; Michel, A.; Degregorio, R.; Carter, L.; Pillarsetty, N.; Poirier, J. T.; Lewis, J. S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Conserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs new combination cancer therapy strategies
    Journal Article

    Glasner, A.; Rose, S. A.; Sharma, R.; Gudjonson, H.; Chu, T.; Green, J. A.; Rampersaud, S.; Valdez, I. K.; Andretta, E. S.; Dhillon, B. S.; more...
    Nature Immunology (2023)

    Fulltext@MSK | Save
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • Characterizing SMARCA4/STK11/KEAP1 co-mutant lung adenocarcinoma
    Meeting Abstract

    Costa, E.; Wohlheiter, C.; Tischfield, S.; Funnell, A.; Poirier, J. T.; Villalonga, A. Q.; Sen, T.; Rudin, C.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC
    Meeting Abstract

    Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save